Tag:
Vpriv
Latest Headlines
Latest Headlines
Shire to boost Vpriv, Replagal with EMA-approved plant
Shire 's rare-disease challenge is heating up.
Shire: Safe to switch from Genzyme meds to Replagal, Vpriv
Shire unveiled top-line data from new studies suggesting it's safe for Fabry disease patients to switch to Replagal from Genzyme's Fabrazyme, which has been running scarce for some time. In addition,
Genzyme set for Cerezyme supply boost
It's good news and bad news for Genzyme . The good news is that the company has written patients to say it will boost shipments of its Gaucher disease drug Cerezyme next month, just as it promised
Ongoing Genzyme shortages boost Shire meds
There's at least one entity who is benefiting from Genzyme's ongoing manufacturing woes, and that's Shire. Since the closure of a plant touched off shortages of Genzyme's drugs, Shire's rival meds
